Correlation Between Acurx Pharmaceuticals and Immutep

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acurx Pharmaceuticals and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acurx Pharmaceuticals and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acurx Pharmaceuticals LLC and Immutep Ltd ADR, you can compare the effects of market volatilities on Acurx Pharmaceuticals and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acurx Pharmaceuticals with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acurx Pharmaceuticals and Immutep.

Diversification Opportunities for Acurx Pharmaceuticals and Immutep

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Acurx and Immutep is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Acurx Pharmaceuticals LLC and Immutep Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Ltd ADR and Acurx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acurx Pharmaceuticals LLC are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Ltd ADR has no effect on the direction of Acurx Pharmaceuticals i.e., Acurx Pharmaceuticals and Immutep go up and down completely randomly.

Pair Corralation between Acurx Pharmaceuticals and Immutep

Given the investment horizon of 90 days Acurx Pharmaceuticals LLC is expected to under-perform the Immutep. In addition to that, Acurx Pharmaceuticals is 1.55 times more volatile than Immutep Ltd ADR. It trades about -0.21 of its total potential returns per unit of risk. Immutep Ltd ADR is currently generating about -0.01 per unit of volatility. If you would invest  231.00  in Immutep Ltd ADR on September 15, 2024 and sell it today you would lose (13.00) from holding Immutep Ltd ADR or give up 5.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Acurx Pharmaceuticals LLC  vs.  Immutep Ltd ADR

 Performance 
       Timeline  
Acurx Pharmaceuticals LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acurx Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Immutep Ltd ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Immutep is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Acurx Pharmaceuticals and Immutep Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acurx Pharmaceuticals and Immutep

The main advantage of trading using opposite Acurx Pharmaceuticals and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acurx Pharmaceuticals position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.
The idea behind Acurx Pharmaceuticals LLC and Immutep Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators